ResearcherUniversity of CambridgeNo recent work listed
Charles R. Dunlop
Matched on ORCID iD 0000-0002-8194-2598; OpenAlex author ID A5082497402. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper
Papers 4
- Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal Imaging. Co-author DOI 10.1021/acs.analchem.1c04579↗
- Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models. Co-author DOI 10.1038/s41416-020-1016-2↗
- Targeting the DNA damage response protein ATR kinase in pancreatic cancer Co-author DOI 10.17863/cam.62227↗
- The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression. First author DOI 10.1158/1535-7163.mct-18-0010↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yann Wallez · 3 shared papers, 2018–2022 · strength 0.30
- Paper Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic … DOI 10.1038/s41416-020-1016-2↗
- Paper Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multim… DOI 10.1021/acs.analchem.1c04579↗
- Paper The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma R… DOI 10.1158/1535-7163.mct-18-0010↗
- Frances M. Richards · 3 shared papers, 2018–2022 · strength 0.30
- Paper Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic … DOI 10.1038/s41416-020-1016-2↗
- Paper Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multim… DOI 10.1021/acs.analchem.1c04579↗
- Paper The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma R… DOI 10.1158/1535-7163.mct-18-0010↗
- Duncan Ian Jodrell · 3 shared papers, 2018–2022 · strength 0.30
- Paper Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic … DOI 10.1038/s41416-020-1016-2↗
- Paper Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multim… DOI 10.1021/acs.analchem.1c04579↗
- Paper The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma R… DOI 10.1158/1535-7163.mct-18-0010↗
- Brajesh Pratap Kaistha · 1 shared paper, 2022 · strength 0.11
- Simon T. Barry · 1 shared paper, 2022 · strength 0.11
- Nicole Strittmatter · 1 shared paper, 2022 · strength 0.11
- Aarthi Gopinathan · 1 shared paper, 2022 · strength 0.11
- Rebecca J. Brais · 1 shared paper, 2022 · strength 0.11
- Owen James Sansom · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.